India's budget finance minister has today announced a tax exemption
on all services carried out by its contract research and clinical
trials industry – a saving of 12.24 per cent.
MDS pharma has ceased operations at its bioanalytical services
facility in Blainville, Quebec in a bid to boost profitability
after an ongoing investigation of the site by the US Food and Drug
Administration (FDA).
Pfizer's latest cutbacks will provide a new outsourcing opportunity
for contract manufacturing organisations (CMOs) in low-cost
destinations as the drug giant announces plans to double its amount
of drug production outsourcing.
MDS has announced it will help its customers confirm or repeat
analyses done at its contract research facilities in Quebec, after
the Food and Drug Administration (FDA) urged some drug makers to
retest products because of concerns...
Melbourn Scientific has invested in a light obscuration particle
counter to size and count particles in liquid samples using light
microscopy, to expand the company's capacity in stability testing
and to increase throughput and...
India's Dishman Pharmaceuticals & Chemicals is planning to snap
up biotech and nanotech contract research organisation (CRO)
companies in Europe and in the US within drug conjugates to expand
their biologics capability.
LAB Research has completed a $12m facility expansion in Canada that
will increase its preclinical testing services capacity at the site
by 40 per cent.
A number of executives and technical staff at small to medium size
pharmaceutical firms are unaware of how to use their resources
effectively to comply with new EMEA guidelines, designed to
minimise the environmental impact of compounds,...
MDS has been heavily impacted by a US Food and Drug Administration
procedural review of its bioanalytical operations, but still
managed to report quarterly earnings of C$53m (€35m).
AAIPharma has announced it has signed a contract manufacturing
agreement with Mallinckrodt Pharmaceuticals Outsourcing which aims
to provide a "one-stop drug development solution" for drug makers.
Evotec AG has sold its cell analysis instrument division, Evotech
Technologies, to PerkinElmer to allow it to focus more keenly on
its drug discovery pipeline and drug discovery services divisions.
Singapore has successfully completed the first phase of its
biomedical science (BMS) initiative and is now pushing the second
phase forward in order to drive growth in its pharma industry
further.
British-based analysis services provider Intertek ASG has announced
it is expanding its analytical services to meet the growing demand
for macromolecule characterisation.
Although manufacturing is the most established of the pharma
outsourcing segments, many service areas are still rapidly
evolving. OutsourcingPharma.com gives a brief run down of the
current state of play.
Curalogic, a Danish biotechnology company, has appointed SAFC's
Pharma business segment to provide protein isolation, extraction
and purification services as part of its product development to
treat Allergic Rhinitis.
Minimising the risk of cross-contamination in the production of
medicines for use in clinical trials is a major challenge for
manufacturers, who need to implement safety measures in order to
avoid production failure.
As it steps up its presence in the major clinical trials
recruitment hubs in Asia, Quintiles has announced its intention to
open a central lab in India to help feed its expanding network of
clinical trial operations in the country.
Agilent Technologies has chosen Distek to be its number-one
provider for dissolution instrumentation service in North America
under its Lab Resource Management (LRM) programme.
Following numerous manufacturing failures, Discovery Laboratories
believes it has resolved the stability issues that have plagued
Surfaxin, its experimental respiratory treatment for infants, and
is now seeking a meeting with the...
US contract pharmaceutical manufacturer Metrics has announced a
$17.5m (€13.7m) investment to double the size of its drug testing
and manufacturing plant over the next three years.
Chemir Analytical Services, the new owner of Gateway Chemical
Technology, has renamed the custom chemical analysis business
IQsynthesis in a revamp effort.
Successful technology transfer and effective management can help
avoid disappointment with contract manufacturing arrangements,
which often fail to live up to pharmaceutical company expectations.
Drug testing services provider Xceleron has set up new facilities
in the US after regulations recently introduced by the Food and
Drug Administration (FDA) are setting this industry sector ablaze.
A good selection process, with a realistic set of selection
criteria is essential when looking for the right contract
manufacturing partner, according to a new Datamonitor report.
Offshoring contract manufacturing is not the only option for large
pharma firms looking to drive productivity and efficiency gains in
drug manufacturing, warns a new report from independent market
analyst Datamonitor.
New research show that the outsourcing trend is set to drive the
analytical laboratory market over the next seven years, however
small labs are in danger of drowning in the process.
Dalton Pharma Services has introduced a range of new medicinal
chemistry services that are available to companies involved in drug
discovery that wish to utilise additional scientific and managerial
expertise as well as specialised...
Contract research organisation iNovacia is expanding its compound
library by increasing the number of compound storage modules in a
bid to cope with new contracts.
Inspection and certification group SGS has officially launched a
laboratory in Shanghai dedicated to quality control testing of
pharmaceuticals, biopharmaceuticals and medical devices, as China's
appetite for contract analytical...
After recently opening up shop in nearby Singapore, SGS has now
brought its contract testing services to neighbouring China to
continue to cash in on the demand for such services in the
Asia-Pacific region.
China-based Natural Pharmatech has formed its first research
contract with a Japanese company, Kobayashi Pharmaceutical -
another step forward in Natural Pharmatech's plans to bring its
botanical R&D services to the global...
GE Healthcare has launched a new contract offering that it claims
will cut the cost of running the service operations in life science
R&D labs by up to 20 per cent, at a time when pharma and
biotech firms are facing intense cost...
US-based MicroTest Laboratories (MTL) has won two new manufacturing
contracts after a facility expansion completed last year allowed
the company to expand into making commercial-scale products.
Oman Pharmaceutical Products (OPP) has entered its first
outsourcing partnership in Europe with Finnish company
Dragenopharm, providing the first step in its strategy to offer
contract manufacturing services globally.
the exponential growth of data points flowing into clinical study databases. As technologies help researchers to reach more patients all over the world,...
Solvents are defined as organic chemicals that are used to dissolve components. They are used during the manufacture of drug substances and can also potentially...
